|
Volumn 170, Issue 11, 2004, Pages 1665-1667
|
Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: Recommendation statement from the Canadian Task Force on Preventive Health Care
a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
CALCIUM;
ESTROGEN;
ETIDRONIC ACID;
GESTAGEN;
PAMIDRONIC ACID;
PARATHYROID HORMONE;
RALOXIFENE;
RISEDRONIC ACID;
VITAMIN D;
BONE DENSITY;
BONE MINERAL;
DISEASE PREDISPOSITION;
FRAGILITY FRACTURE;
HIGH RISK POPULATION;
HORMONE SUBSTITUTION;
HUMAN;
LIFESTYLE;
POSTMENOPAUSE OSTEOPOROSIS;
PREVENTIVE MEDICINE;
RISK ASSESSMENT;
RISK REDUCTION;
SHORT SURVEY;
TREATMENT OUTCOME;
|
EID: 2942604221
PISSN: 08203946
EISSN: None
Source Type: Journal
DOI: 10.1503/cmaj.1030757 Document Type: Short Survey |
Times cited : (66)
|
References (6)
|